Venture Life Group PLC · LSE:VLG
Venture Life — MELLO London Conference 2023
14 slides from Venture Life's conference presentation, November 2023
Slide 1: The partner of choice for self-care products
The partner [ of choice for self-care products MELLO LONDON Conference November 2023 The partner of choice or self-care products enture Life Group plc [ nterim Results 2021 and update on Acquisitions ptember 2021
Slide 2: Fully integrated consumer self-care
Venture Life Group Fully integrated consumer self-care Venture Life develops, manufactures, and distributes non-drug, OTC products for the self- care market to enable and empower consumers to lead healthier lives. Value Culture Mission Vision Teamwork Innovation Provide accessible, Fun Create sustai
Slide 3: Our Business Model
Venture Life Group Our Business Model Omni-channel Strong Distribution retail partnerships … and more VLG Brands Customer Brands Private Label 3 revenue streams 2 manufacturing Italy Sweden centers Full CDMO capabilities
Slide 4: Strong growth underpinned by improving profitability
Strong growth underpinned by improving profitability Financial overview Revenue Adj. EBITDA (￡/%) (2018-2022) (2018-2022) 50 20.4% (￡mln) 10 30% (￡mln) 40 8 44.0 20% 6 30 32.8 4 9.0 26.7 6.6 10% 20 2 4.0 20.2 2.7 3.0 18.8 10 0 0% 2018 2019 2020 2021 2022 0 2018 2019 2020 2021 2022 Adj. EBITDA Adj. E
Slide 5: VLG Brands: products and category focus
VLG Brands (including Private Label) Products and category focus, significant ‘build-out’ opportunity Registered Medical Devices, Cosmetics and Food Supplements Energy ENT Oral Care Women’s Health Management Ear wax softening, treatment Halitosis, Anti-Plaque, Anti- Bacterial Vaginosis, Atrophy, Hyp
Slide 6: Main VLG Brands UK distribution
Oral Care, Women’s Health, Energy Management, ENT Treatment Main VLG Brands UK distribution *As of October 2023
Slide 7: Regulatory Change: EU Medical Device Regulation
EU Medical Device Regulation Regulatory Change • The enforcement of new regulations (Medical Device Regulations – MDR) is set to impact medical device products in the UK and EU • All medical devices must transition to more stringent set of rules • Many existing medical devices expected to fall outsi
Slide 8: Distribution network: expanded global presence
Distribution network Expanded global presence 200+ 90+ Partners Markets worldwide worldwide 4 161 Operational Employees locations * As of January 2023 Retail Partners International Partners UK Head and Commercial Office Netherlands Office Italian Development and Manufacturing Facility Sweden Manufac
Slide 9: R&D and manufacturing capability
Vertically integrated R&D and manufacturing capability (As of June 2023) • 40 years of experience in Italy Units produced LTM 35m units developing consumer • 5,500m2 facility located near Milan Existing capacity 65m units healthcare products • 13 filling lines • Strong R&D and technical Capacity wit
Slide 10: Biokosmes Srl - our Italian CDMO facility
An entrusted CDMO partner for Customer Brands Biokosmes Srl - our Italian CDMO facility First Medical Founded as a Device pure-play R&D Started Development manufacturing license Merged with Venture Life First FDA Approval 1983 1990 1999 2002 2014 Ideation Production R&D 1,500 FULL SERVICE formulatio
Slide 11: Development milestones: Buy-and-build
Buy-and-build Development milestones 2027 2022 • Target: 2021 Revenue reaches ￡100m 2020 2018 √ Acquisition of 2016 Earol brand 2014 √ Acquisition of 2010 √ Acquisition Balance Activ and Lift √ Acquisition of of portfolio of brands, and footcare √ Acquisition of Dentyl brand Gnesta products UltraDEX
Slide 12: ESG: Sustainability at the core
Sustainability at the core ESG (Data based on Biokosmes factory) UN Sustainable Development Goals 77% 20% CO2 manufacturing emission electricity reduction in generated from 20221 solar in 2022 100% 27% 3 customer satisfaction of of waste green projects material development2 recycled2 5-step ESG Appr
Slide 13: Experienced Management Team
Experienced Management Team Jerry Randall Gianluca Braguti Daniel Wells Chief Executive Officer Chief Manufacturing Officer Chief Financial Officer • Extensive experience in • Pharmacist graduate • Chartered accountant international licensing, M&A, • Over 15 years' experience in • Founded Biokosmes
Slide 14: Empowering Every Day, Enhancing Every Life
Contact Empowering Every Day Enhancing Every Life UK (Headquarters) 12 The Courtyard, Eastern Road, Bracknell, Berkshire +44 1344 578004 General Inquiries/PR: [email protected] Business Development [email protected] Investor Relations [email protected] Italy Sweden The Netherlands Via dei Li